- Home
- BPMC vs GGB Comparison
BPMC vs GGB Comparison
Compare BPMC & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- GGB
- Stock Information
- Founded
- BPMC 2008
- GGB 1901
- Country
- BPMC United States
- GGB Brazil
- Employees
- BPMC N/A
- GGB N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- GGB Steel/Iron Ore
- Sector
- BPMC Health Care
- GGB Industrials
- Exchange
- BPMC Nasdaq
- GGB Nasdaq
- Market Cap
- BPMC 5.8B
- GGB 5.5B
- IPO Year
- BPMC 2015
- GGB 1999
- Fundamental
- Price
- BPMC $97.17
- GGB $2.62
- Analyst Decision
- BPMC Buy
- GGB Buy
- Analyst Count
- BPMC 21
- GGB 2
- Target Price
- BPMC $124.05
- GGB $3.95
- AVG Volume (30 Days)
- BPMC 973.2K
- GGB 8.7M
- Earning Date
- BPMC 05-01-2025
- GGB 04-28-2025
- Dividend Yield
- BPMC N/A
- GGB 3.98%
- EPS Growth
- BPMC N/A
- GGB N/A
- EPS
- BPMC N/A
- GGB 0.27
- Revenue
- BPMC $562,121,000.00
- GGB $11,893,560,444.00
- Revenue This Year
- BPMC $44.85
- GGB $6.19
- Revenue Next Year
- BPMC $32.06
- GGB $5.40
- P/E Ratio
- BPMC N/A
- GGB $9.25
- Revenue Growth
- BPMC 99.19
- GGB 2.92
- 52 Week Low
- BPMC $73.04
- GGB $2.27
- 52 Week High
- BPMC $121.90
- GGB $4.04
- Technical
- Relative Strength Index (RSI)
- BPMC 59.54
- GGB 49.02
- Support Level
- BPMC $87.03
- GGB $2.49
- Resistance Level
- BPMC $104.86
- GGB $2.67
- Average True Range (ATR)
- BPMC 3.86
- GGB 0.07
- MACD
- BPMC 1.24
- GGB 0.01
- Stochastic Oscillator
- BPMC 64.38
- GGB 50.00
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutor, mechanical construction bars, reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives majority of the revenue from the North America Operations segment.